Boehringer Ingelheim, Process Science, Protein Science, Fremont, California, USA.
Boehringer Ingelheim, Manufacturing Science and Technology, Fremont, California, USA.
Biotechnol Bioeng. 2022 Aug;119(8):2115-2121. doi: 10.1002/bit.28117. Epub 2022 Jun 20.
A continuous viral inactivation (CVI) tubular reactor was designed for low pH viral inactivation within a continuous downstream system across multiple scales of operation. The reactors were designed to provide a minimum residence time of >60 min. The efficacy of this tubular reactor was tested with xenotropic murine leukemia virus (X-MuLV) through pulse injection experiments. It was determined that the minimum residence time of the small-scale reactor design, when operated at the target process flow rate, occurred between 63 and 67 min. Inactivation kinetics were compared between continuous operation and standard batch practices using three monoclonal antibodies. The quantification of the virus log reduction values (LRV) was similar between the two modes of operation and most of the acid-treated samples had virus concentrations below the limit of detection. However, residual infectivity was still present in the endpoint batch samples of two experiments while the continuous samples always remained below the limit of detection. This provides the foundation for leveraging a standard batch-based model to quantify the LRV for a CVI unit operation.
设计了一种连续病毒灭活(CVI)管式反应器,用于在跨多个操作规模的连续下游系统中对低 pH 值病毒进行灭活。这些反应器的设计目的是提供 >60 分钟的最小停留时间。通过脉冲注射实验,用嗜异性鼠白血病病毒(X-MuLV)测试了该管式反应器的效果。结果表明,当在目标工艺流速下运行时,小规模反应器设计的最小停留时间在 63 到 67 分钟之间。使用三种单克隆抗体比较了连续操作和标准分批操作之间的灭活动力学。两种操作模式下病毒对数减少值(LRV)的定量结果相似,大多数酸处理样品的病毒浓度低于检测限。然而,两个实验的终点分批样品仍存在残留感染性,而连续样品始终低于检测限。这为利用基于标准分批的模型来量化 CVI 单元操作的 LRV 提供了基础。